S. Peter Goedegebuure
Washington University in St. Louis(US)Jewish Hospital(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, vaccines and immunoinformatics approaches, CAR-T cell therapy research
Most-Cited Works
- → CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models(2014)1,264 cited
- → Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial(2016)758 cited
- → Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis(2013)599 cited
- → Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids(2018)281 cited
- → Preclinical and clinical development of neoantigen vaccines(2017)225 cited
- → Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer(2014)216 cited
- → Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression(2020)129 cited
- → Effect of Platelet-Rich Plasma Injections vs Placebo on Ankle Symptoms and Function in Patients With Ankle Osteoarthritis(2021)126 cited
- → Tumor-on-chip modeling of organ-specific cancer and metastasis(2021)117 cited
- → Tumour evolution and microenvironment interactions in 2D and 3D space(2024)115 cited